Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07059962 · ClinicalTrials.gov registry record
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
A clinical trial of Kidney Disease and End Stage Kidney Disease (ESRD), sponsored by Bodyport.
- Recruiting
- Registry status
- 125
- Enrollment target
- 4
- Study locations
NCT07059962: Recruiting study of Kidney Disease and End Stage Kidney Disease (ESRD), sponsored by Bodyport.
NCT07059962 is a study of Kidney Disease and End Stage Kidney Disease (ESRD) that is actively recruiting participants, run by Bodyport. The registered enrollment target is 125 participants, below the 2,934-participant average among 23 other Kidney Disease trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07059962, a study of Kidney Disease and End Stage Kidney Disease (ESRD), is actively recruiting participants, sponsored by Bodyport.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 4
- Study locations
Study Summary
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
Primary Outcome
Sensitivity for predicting usable PDE \> 0.40 and an alert rate of \< 4.3 alerts per patient-year.
Conditions Studied
Interventions
- DEVICE Bodyport Cardiac Scale
Study Locations (4)
California
- Desert Cities Dialysis - Victorville
Georgia
- Southeastern Clinical Research Institute - Augusta
Illinois
- Northwestern University - Chicago
Manitoba
- Seven Oaks General Hospital - Winnipeg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-09-09 |
| Est. Completion | 2026-06 |
What NCT07059962 shows while recruiting
NCT07059962 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 2,934-participant average among 23 other Kidney Disease trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Bodyport Cardiac Scale is the first listed.
NCT07059962 reports a single indexed study location in California, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT07059962 about?
NCT07059962 is a clinical study titled "Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)". To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
What is the current status of trial NCT07059962?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2025-09-09. Estimated completion is 2026-06.
What conditions does trial NCT07059962 study?
This clinical trial studies the following conditions: Kidney Disease, End Stage Kidney Disease (ESRD), Peritoneal Dialysis (PD).
What interventions are being tested in trial NCT07059962?
The interventions under investigation include: Bodyport Cardiac Scale (DEVICE).
Who is sponsoring clinical trial NCT07059962?
This trial is sponsored by Bodyport, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07059962 being conducted?
This trial has 4 study locations across California, Georgia, Illinois, Manitoba. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07059962's enrollment target sits among peer trials
125 11th of 23 higher than 13 of 23 other Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rutgers University Study of the Genetics of Kidney Disease
RECRUITING
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
-
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
RECRUITING · Phase 3
-
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
RECRUITING · Phase 2
-
Inspire HER: Inspiring the Heart and Emotions for Radical Health
RECRUITING · NA
-
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI